Skip to main content
Log in

House dust mite SLIT cost effective for persistent allergic rhinitis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. allergy immunotherapy

Reference

  • Green W, et al. Cost-effectiveness of SQ HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany. ClinicoEconomics and Outcomes Research 2017: 77-84, No. 9, 16 Feb 2017. Available from: URL: https://doi.org/10.2147/CEOR.S115931

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

House dust mite SLIT cost effective for persistent allergic rhinitis. PharmacoEcon Outcomes News 772, 21 (2017). https://doi.org/10.1007/s40274-017-3769-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3769-2

Navigation